News Flash 03.10.2013

-September 2014: S-TARget closes world wide exclusive license deal with Allergopharma for the development of therapeutic allergy vaccines based on S-TARget’s proprietary S-TIR technology platform.

-September 2013: S-TARget achieves clinical in vivo PoC with SG100 in placebo controlled clinical NHP model for house dust mite induced chronic severe allergic asthma at ECU (USA). Significant improvement of both EAR and LAR clinical symptoms.

-May 2013: S-TIR technology platform for use in oncology out licensed to OncoQR ML

-May 2013: Start In Vivo PoC II with Clinical Candidate SG100 at East Carolina university (USA). Treatment of NHP suffering from house dust mit induced chronic allergic asthma

-April 2013: S-TARget achieves immunological  in vivo PoC in clinically relevant animal model at BPRC (NL)

-March 2013: Promotion film SG100 published on YouTube: 

-January 2013: S-TARget has moved its headquaters to Mooslackengasse 17 , 1190 Vienna, Austria

-December 2012: Start In Vivo PoC I with Clinical Candidate SG100 at BPRC (NL)

-September 2012: 2nd Tranch Seed Funding AWS Released

-August 2012: Clinical Candidate SG100 for treatment of House Dust Mite induced Allergic Asthma available

-March 2011: Winner concept phase of Science4Life (German BP contest)

-January 2011: Collaboration to implement a model of allergic asthma initiated  with Prof. Van Scott, East Carolina University (USA).

-December 2010: Seed Financing by AWS awarded

-December 2010: Confirmation of warhead proof of concept on monkey Plasmacytoid Dendirtic cells (BPRC)

-November 2010: FFG grant awarded

-October 2010: Top 5 at Best of Biotech 2010 (Austrian BP contest)

-September 2010: Primocid (EU) grant received

-September 2010: S-TARget therapeutics GmbH founded

-June 2010: Start of collaboration with Prof. Reingard Grabherr, University of Natural Ressources and Life Sciences, Vienna

-March 2010: start of collaboration with BPRC, Rijswijk, The Netherlands

-February 2010: AWS Pre-Seed grant awarded

-December 2009: INiTS grant awarded

-August 2009: In vitro proof of concept with warhead on human Plasmacytoid Dendritic cells (Radboud University)

-June 2009: Start collaboration on human Plasmacytoid Dendritic cells with Prof. Jolanda de Vries, Radboud University, Nijmegen, the Netherlands